Med Connect Solutions Private Limited
Founded: 2010
Status: Strike Off
Designation: Director
NS
Nivedita Ravishankar Srivastava - Profile
Nivedita Ravishankar Srivastava, Director, with 5 companies across 1 industry.
About
Nivedita Ravishankar Srivastava
Nivedita Ravishankar Srivastava has 28 years in corporate governance. Holds Director role. Currently with 1 company, including Med Connect Solutions Private Limited. Formerly with 4 companies, such as Shruti Medi-Science Private Limited and Invent Bio-Med Private Limited. Engaged in General Business. Contributes to corporate operations.
Current Companies
1
Past Companies
4
Total Affiliations
5
Oldest Company Age
15
Companies Associated with Nivedita Ravishankar Srivastava
Current Companies
Previous Companies
Shruti Medi-Science Private Limited
Founded: 1997
Status: Active
Designation: Director
Invent Bio-Med Private Limited
Founded: 2005
Status: Active
Designation: Director
Invent Bio-Med Private Limited
Founded: 2005
Status: Active
Designation: Whole-Time Director
Shruti Medi-Science Private Limited
Founded: 1997
Status: Active
Designation: Managing Director
Explore Director's current and past company associations— Uncover their professional journey today!
Frequently Asked Questions
Who is Nivedita Ravishankar Srivastava?
Nivedita Ravishankar Srivastava has 28 years in corporate governance. Holds Director role. Currently with 1 company, including Med Connect Solutions Private Limited. Formerly with 4 companies, such as Shruti Medi-Science Private Limited and Invent Bio-Med Private Limited. Engaged in General Business. Contributes to corporate operations.
What is Nivedita Ravishankar Srivastava's role in current companies?
Nivedita Ravishankar Srivastava is associated with 1 company as Director.
What industries does Nivedita Ravishankar Srivastava specialize in?
Nivedita Ravishankar Srivastava has expertise in General Business.
How many years of experience does Nivedita Ravishankar Srivastava have?
Nivedita Ravishankar Srivastava has 28 years in corporate governance.